Susan M. O’Brien, MD of University of California Irvine discusses the preferred frontline regimen for new CLL patients greater than 70 years at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
www.scrippshealth.org/cancer